Pruritus Treatment Pipeline Research 2024: Comprehensive Insights about 20+ Companies and 25+ Drugs - Therapeutics Assessment by Product Type, Stage, Route of Administration, and Molecule Type
28. Juni 2024 11:08 ET
|
Research and Markets
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Pruritus - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Pruritus - Pipeline Insight, 2024" report...
Uremic Pruritus Pipeline Insight 2024, Featuring Key Players Cara Therapuetics and Lumosa Therapeutics, and Key Emerging Drugs Cara Therapeutics CR845 and Lumos Therapeutics' LT 5001
22. April 2024 05:00 ET
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Uremic Pruritus - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report provides comprehensive...
Pruritus Therapeutics Market Analysis Reveals Promising Growth Opportunities by 2030
24. Januar 2024 08:48 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Pruritus Therapeutics Market by Therapy (Antihistamines, Calcineurin Inhibitors, Corticosteroids), Disease Indication (Allergic Contact...
Global Pruritus Therapeutics Market Report 2022: High Demand for Over The Counter Medications Boosts Growth
10. November 2022 05:41 ET
|
Research and Markets
Dublin, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The "Pruritus Therapeutics Market By Drug type, By Disease Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031"...